2026 ICD-10-CM Diagnosis Code J84.89Other specified interstitial pulmonary diseases

ICD-10-CM CodesJ00–J99J80-J84J84

ICD-10-CM J84.89
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

J84.89 is a billable ICD-10-CM diagnosis code for other specified interstitial pulmonary diseases. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 196 through 198. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified lower respiratory disease.

Code Identity

ICD-10-CM Code
J84.89
Billable Status
Yes — Valid for Submission
Code Describes
Other specified interstitial pulmonary diseases
Short Description
Other specified interstitial pulmonary diseases
Same as the full description in the CMS dataset.
Parent Code
Other specified interstitial pulmonary diseases

Code Classification

ChapterJ00–J99Diseases of the respiratory system
SectionJ80-J84Other respiratory diseases principally affecting the interstitium
CategoryJ84Other interstitial pulmonary diseases
This CodeJ84.89Other specified interstitial pulmonary diseases

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acute endogenous lipoid pneumonitis
  • Cholesterol pneumonitis
  • Chronic chemical respiratory disease
  • Chronic endogenous lipoid pneumonitis
  • Chronic pneumonitis of infancy
  • Deficiency of DNA repair
  • Diffuse pulmonary meningotheliomatosis
  • DNA repair
  • Endogenous lipoid pneumonitis
  • GIP - Giant cell interstitial pneumonitis
  • Interstitial lung disease due to ABCA3 deficiency
  • Interstitial pneumonitis
  • Lipoid pneumonitis
  • Lung disease, immunodeficiency, chromosome breakage syndrome
  • Organized pneumonia
  • Usual interstitial pneumonitis
  • Vinyard sprayers' lung

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Endogenous lipoid pneumonia
  • Interstitial pneumonitis
  • Non-specific interstitial pneumonitis NOS
  • Organizing pneumonia NOS

Code First

  • , if applicable:
  • poisoning due to drug or toxin T51 T65
  • underlying cause of pneumonopathy, if known

Use Additional Code

  • code, for adverse effect, to identify drug T36 T50

Type 1 Excludes

  • cryptogenic organizing pneumonia J84.116
  • idiopathic non-specific interstitial pneumonitis J84.113
  • lipoid pneumonia, exogenous or unspecified J69.1
  • lymphoid interstitial pneumonia J84.2

Index to Diseases and InjuriesGuidance

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • BOOP(bronchiolitis obliterans organized pneumonia)
    • Bronchiolitis(acute) (infective) (subacute)
      • obliterans
        • with organizing pneumonia (BOOP)
    • Disease, diseased
      • lung
        • interstitial
          • specified NEC
    • Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved)
      • bronchiolitis obliterans organized (BOOP)
    • Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved)
      • broncho-, bronchial (confluent) (croupous) (diffuse) (disseminated) (hemorrhagic) (involving lobes) (lobar) (terminal)
        • lipid, lipoid
          • endogenous
    • Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved)
      • cholesterol
    • Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved)
      • interstitial
        • non-specific
    • Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved)
      • lipid, lipoid (exogenous)
        • endogenous
    • Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved)
      • organizing
    • Pneumonitis(acute) (primary)
      • cholesterol
    • Pneumonitis(acute) (primary)
      • interstitial (chronic)
    • Pneumonitis(acute) (primary)
      • interstitial (chronic)
        • non-specific

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR RSP016
Other specified and unspecified lower respiratory disease
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • DNA End-Joining Repair

    the repair of double-strand dna breaks by rejoining the broken ends of dna to each other directly.
  • DNA Repair

    the removal of dna lesions and/or restoration of intact dna strands without base pair mismatches, intrastrand or interstrand crosslinks, or discontinuities in the dna sugar-phosphate backbones.
  • DNA Repair Enzymes

    enzymes that are involved in the reconstruction of a continuous two-stranded dna molecule without mismatch from a molecule, which contained damaged regions.
  • DNA Repair-Deficiency Disorders

    disorders resulting from defective dna repair processes or the associated cellular responses to dna damage.
  • O(6)-Methylguanine-DNA Methyltransferase

    an enzyme that transfers methyl groups from o(6)-methylguanine, and other methylated moieties of dna, to a cysteine residue in itself, thus repairing alkylated dna in a single-step reaction. ec 2.1.1.63.
  • Rad52 DNA Repair and Recombination Protein

    a dna-binding protein that mediates dna repair of double strand breaks, and homologous recombination.
  • Recombinational DNA Repair

    repair of dna damage by exchange of dna between matching sequences, usually between the allelic dna (alleles) of sister chromatids.
  • DNA

    a deoxyribonucleotide polymer that is the primary genetic material of all cells. eukaryotic and prokaryotic organisms normally contain dna in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. dna, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).

Patient EducationClinical

Interstitial Lung Diseases

Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert J84.89 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
515 Postinflam pulm fibrosis
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About J84.89Overview

Is J84.89 (Other specified interstitial pulmonary diseases) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other specified interstitial pulmonary diseases on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does J84.89 group to?

When other specified interstitial pulmonary diseases is the principal diagnosis on an inpatient stay, it groups to MS-DRG 196, 197, 198, with relative weights from 0.7162 to 1.8872 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of J84.89?

Under the General Equivalence Mappings, other specified interstitial pulmonary diseases converts to ICD-9-CM 515 (postinflam pulm fibrosis). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.